You're viewing a public preview of Prime European Therapeuticals SpA Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Prime European Therapeuticals SpA

Inactive PE Backed
V.le Milano, 86/88,  Lodi,  26900,  Italy
Sector: Life Science Entity: Private
Acquired Prime European Therapeuticals SpA acquired by Albany Molecular Research, Inc., Clessidra SGR S.p.A., Mandarin Capital Management SA in 2016
2
Transactions
Sign up to view
$358M
Deal Value
Sign up to view
About Prime European Therapeuticals SpA
Within the Acquity Data private market database, Prime European Therapeuticals SpA operates in the Life Science sector. The company is classified under the Life Science sector. The company is headquartered in Lodi. Prime European Therapeuticals SpA is profiled within Acquity Data.
Investors
Current Investors
Albany Molecular Research, Inc. Clessidra SGR S.p.A. Mandarin Capital Management SA ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Prime European Therapeuticals SpA M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Prime European Therapeuticals SpA do?
Within the Acquity Data private market database, Prime European Therapeuticals SpA operates in the Life Science sector. The company is classified under the Life Science sector. The company is headquartered in Lodi. Prime European Therapeuticals SpA is profiled within Acquity Data.
Where is Prime European Therapeuticals SpA headquartered?
Prime European Therapeuticals SpA is headquartered in Lodi, Italy.
When was Prime European Therapeuticals SpA founded?
Founded year information for Prime European Therapeuticals SpA is available on AcquityData.
What sector is Prime European Therapeuticals SpA in?
Prime European Therapeuticals SpA operates in the Life Science sector.
Who are the investors in Prime European Therapeuticals SpA?
Current investors in Prime European Therapeuticals SpA include Albany Molecular Research, Inc., Clessidra SGR S.p.A., Mandarin Capital Management SA. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Prime European Therapeuticals SpA been involved in?
Prime European Therapeuticals SpA has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Prime European Therapeuticals SpA profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Prime European Therapeuticals SpA's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial